Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023

Upgrades

According to Macquarie, the prior rating for Lufax Holding Ltd LU was changed from Underperform to Outperform. For the fourth quarter, Lufax Holding had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The current stock performance of Lufax Holding shows a 52-week-high of $7.05 and a 52-week-low of $1.26. Moreover, at the end of the last trading period, the closing price was at $1.64.

Barrington Research upgraded the previous rating for Warner Bros. Discovery Inc WBD from Market Perform to Outperform. For the first quarter, Warner Bros. Discovery had an EPS of $0.44, compared to year-ago quarter EPS of $0.69. The current stock performance of Warner Bros. Discovery shows a 52-week-high of $18.76 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $12.81.

According to Exane BNP Paribas, the prior rating for NEXTracker Inc NXT was changed from Neutral to Outperform. At the moment, the stock has a 52-week-high of $40.50 and a 52-week-low of $28.24. NEXTracker closed at $40.32 at the end of the last trading period.

Argus Research upgraded the previous rating for Royal Caribbean Group RCL from Hold to Buy. Royal Caribbean Gr earned $0.23 in the first quarter, compared to $4.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.38 and a 52-week-low of $31.09. Royal Caribbean Gr closed at $76.12 at the end of the last trading period.

According to Argus Research, the prior rating for Canadian Pacific Kansas City Ltd CP was changed from Hold to Buy. For the first quarter, Canadian Pacific Kansas had an EPS of $0.90, compared to year-ago quarter EPS of $0.53. The current stock performance of Canadian Pacific Kansas shows a 52-week-high of $83.18 and a 52-week-low of $65.22. Moreover, at the end of the last trading period, the closing price was at $82.93.

Keefe, Bruyette & Woods upgraded the previous rating for Ellington Financial Inc EFC from Market Perform to Outperform. In the first quarter, Ellington Financial showed an EPS of $0.45, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.37 and a 52-week-low of $10.81. Ellington Financial closed at $12.46 at the end of the last trading period.

Deutsche Bank upgraded the previous rating for Veris Residential Inc VRE from Hold to Buy. In the first quarter, Veris Residential showed an EPS of $0.15, compared to $0.09 from the year-ago quarter. The current stock performance of Veris Residential shows a 52-week-high of $17.69 and a 52-week-low of $10.21. Moreover, at the end of the last trading period, the closing price was at $16.24.

According to Gordon Haskett, the prior rating for Expedia Group Inc EXPE was changed from Hold to Buy. For the first quarter, Expedia Group had an EPS of $0.20, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $135.35 and a 52-week-low of $82.39. Expedia Group closed at $92.23 at the end of the last trading period.

For NovoCure Ltd NVCR, Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. NovoCure earned $0.50 in the first quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.05. NovoCure closed at $77.82 at the end of the last trading period.

According to Citigroup, the prior rating for Williams Companies Inc WMB was changed from Neutral to Buy. In the first quarter, Williams Companies showed an EPS of $0.56, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.95 and a 52-week-low of $27.80. Williams Companies closed at $29.10 at the end of the last trading period.

For Gilead Sciences Inc GILD, BMO Capital upgraded the previous rating of Market Perform to Outperform. Gilead Sciences earned $1.37 in the first quarter, compared to $2.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $89.61 and a 52-week-low of $57.17. Gilead Sciences closed at $78.38 at the end of the last trading period.

According to Barclays, the prior rating for Amdocs Ltd DOX was changed from Equal-Weight to Overweight. Amdocs earned $1.47 in the second quarter, compared to $1.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $97.08 and a 52-week-low of $76.79. Amdocs closed at $91.01 at the end of the last trading period.

For Palomar Holdings Inc PLMR, Keefe, Bruyette & Woods upgraded the previous rating of Market Perform to Outperform. For the first quarter, Palomar Hldgs had an EPS of $0.80, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $95.01 and a 52-week-low of $43.64. At the end of the last trading period, Palomar Hldgs closed at $47.11.

New Street Research upgraded the previous rating for America Movil SAB de CV AMX from Neutral to Buy. For the first quarter, America Movil had an EPS of $0.51, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $22.93 and a 52-week-low of $15.68. At the end of the last trading period, America Movil closed at $22.81.

See all analyst ratings upgrades.

Downgrades

For Absolute Software Corp ABST, TD Securities downgraded the previous rating of Buy to Tender. At the moment, the stock has a 52-week-high of $12.57 and a 52-week-low of $7.39. Absolute Software closed at $11.33 at the end of the last trading period.

For NeoGames SA NGMS, Truist Securities downgraded the previous rating of Buy to Hold. In the first quarter, NeoGames showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $10.85. NeoGames closed at $27.17 at the end of the last trading period.

For NeoGenomics Inc NEO, Raymond James downgraded the previous rating of Outperform to Market Perform. For the first quarter, NeoGenomics had an EPS of $0.09, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $20.54 and a 52-week-low of $6.00. NeoGenomics closed at $19.13 at the end of the last trading period.

For CTI BioPharma Corp CTIC, SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the first quarter, CTI BioPharma showed an EPS of $0.10, compared to $0.37 from the year-ago quarter. The current stock performance of CTI BioPharma shows a 52-week-high of $8.96 and a 52-week-low of $3.95. Moreover, at the end of the last trading period, the closing price was at $8.93.

Morgan Stanley downgraded the previous rating for Cullen/Frost Bankers Inc CFR from Overweight to Equal-Weight. Cullen/Frost Bankers earned $2.70 in the first quarter, compared to $1.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $160.31 and a 52-week-low of $92.55. Cullen/Frost Bankers closed at $99.63 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Prosperity Bancshares Inc PB from Equal-Weight to Underweight. Prosperity Bancshares earned $1.37 in the first quarter, compared to $1.33 in the year-ago quarter. The current stock performance of Prosperity Bancshares shows a 52-week-high of $78.76 and a 52-week-low of $56.72. Moreover, at the end of the last trading period, the closing price was at $60.64.

According to Morgan Stanley, the prior rating for Commerce Bancshares Inc CBSH was changed from Equal-Weight to Underweight. In the first quarter, Commerce Bancshares showed an EPS of $0.95, compared to $0.97 from the year-ago quarter. At the moment, the stock has a 52-week-high of $71.87 and a 52-week-low of $48.01. Commerce Bancshares closed at $49.75 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

JonesTrading initiated coverage on Vor Biopharma Inc VOR with a Buy rating. The price target for Vor Biopharma is set to $18.00. In the first quarter, Vor Biopharma showed an EPS of $0.43, compared to $0.61 from the year-ago quarter. The current stock performance of Vor Biopharma shows a 52-week-high of $7.53 and a 52-week-low of $3.50. Moreover, at the end of the last trading period, the closing price was at $4.42.

Truist Securities initiated coverage on Rayonier Inc RYN with a Hold rating. The price target for Rayonier is set to $33.00. For the first quarter, Rayonier had an EPS of $0.01, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $41.96 and a 52-week-low of $27.81. At the end of the last trading period, Rayonier closed at $29.91.

With a Hold rating, Truist Securities initiated coverage on Ardagh Metal Packaging SA AMBP. The price target seems to have been set at $4.00 for Ardagh Metal Packaging. For the first quarter, Ardagh Metal Packaging had an EPS of $0.01, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $7.00 and a 52-week-low of $3.44. At the end of the last trading period, Ardagh Metal Packaging closed at $3.59.

With an Outperform rating, Oppenheimer initiated coverage on GE HealthCare Technologies Inc GEHC. The price target seems to have been set at $97.00 for GE HealthCare Techs. For the first quarter, GE HealthCare Techs had an EPS of $0.85, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of $87.83 and a 52-week-low of $53.00. At the end of the last trading period, GE HealthCare Techs closed at $74.93.

With a Hold rating, Berenberg initiated coverage on Coinbase Global Inc COIN. The price target seems to have been set at $55.00 for Coinbase Glb. Coinbase Glb earned $0.34 in the first quarter, compared to $1.98 in the year-ago quarter. At the moment, the stock has a 52-week-high of $116.30 and a 52-week-low of $31.55. Coinbase Glb closed at $60.77 at the end of the last trading period.

See all analyst ratings initiations.